Skip to content
OpenCapital
Get started

Gyre Therapeutics, Inc. GYRE Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$12.01B+64.2%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$3.76B+38.7%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$835.73M+89.2%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$499.51M+55.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$547.19M+35.0%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10—

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%—

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0×0.0×
Current ratio4.6×+1.0×

Where this comes from

Computed from the period-end share price: $636.46M.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s market capitalization?
Gyre Therapeutics, Inc. (GYRE) reported market capitalization of $636.46M in Q1 2026.
How has Gyre Therapeutics, Inc.'s market capitalization changed year-over-year?
Gyre Therapeutics, Inc.'s market capitalization decreased by 11.9% year-over-year, from $722.69M to $636.46M.
What is the long-term trend for Gyre Therapeutics, Inc.'s market capitalization?
Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s market capitalization has grown at a -41.2% compound annual growth rate (CAGR), from $1.97B to $680.11M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.